Insufficient scRNA-seq data for expression of HTN1 at single-cell level.
Insufficient scRNA-seq data for expression of HTN1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
eye | 0% | 0 | 0 / 0 | 51% | 33.54 | 41 / 80 |
skin | 0% | 0.01 | 2 / 1809 | 19% | 15.24 | 88 / 472 |
adrenal gland | 1% | 0.38 | 2 / 258 | 3% | 0.30 | 8 / 230 |
breast | 0% | 0.22 | 1 / 459 | 2% | 0.37 | 21 / 1118 |
stomach | 0% | 0 | 0 / 359 | 2% | 0.07 | 5 / 286 |
intestine | 0% | 0.01 | 1 / 966 | 1% | 0.06 | 6 / 527 |
prostate | 1% | 0.08 | 2 / 245 | 0% | 0.00 | 1 / 502 |
lung | 0% | 0 | 0 / 578 | 1% | 0.04 | 9 / 1155 |
bladder | 0% | 0 | 0 / 21 | 1% | 0.03 | 3 / 504 |
esophagus | 0% | 0.08 | 7 / 1445 | 0% | 0 | 0 / 183 |
uterus | 0% | 0 | 0 / 170 | 0% | 0.01 | 2 / 459 |
brain | 0% | 0.05 | 8 / 2642 | 0% | 0 | 0 / 705 |
muscle | 0% | 0.09 | 2 / 803 | 0% | 0 | 0 / 0 |
liver | 0% | 0 | 0 / 226 | 0% | 0.01 | 1 / 406 |
thymus | 0% | 0.06 | 1 / 653 | 0% | 0 | 0 / 605 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
adipose | 0% | 0 | 0 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 0% | 0 | 0 / 1335 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
heart | 0% | 0 | 0 / 861 | 0% | 0 | 0 / 0 |
kidney | 0% | 0 | 0 / 89 | 0% | 0 | 0 / 901 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ovary | 0% | 0 | 0 / 180 | 0% | 0 | 0 / 430 |
pancreas | 0% | 0 | 0 / 328 | 0% | 0 | 0 / 178 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_1900026 | Biological process | positive regulation of substrate adhesion-dependent cell spreading |
GO_0035470 | Biological process | positive regulation of vascular wound healing |
GO_0031640 | Biological process | killing of cells of another organism |
GO_0050832 | Biological process | defense response to fungus |
GO_0009893 | Biological process | positive regulation of metabolic process |
GO_1903691 | Biological process | positive regulation of wound healing, spreading of epidermal cells |
GO_0031214 | Biological process | biomineral tissue development |
GO_0022409 | Biological process | positive regulation of cell-cell adhesion |
GO_0042742 | Biological process | defense response to bacterium |
GO_0090303 | Biological process | positive regulation of wound healing |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0005576 | Cellular component | extracellular region |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0005739 | Cellular component | mitochondrion |
GO_0005515 | Molecular function | protein binding |
Gene name | HTN1 |
Protein name | Histatin-1 (Hst1) (Histidine-rich protein 1) (Post-PB protein) (PPB) [Cleaved into: His1-(31-57)-peptide (His1 31/57) (His1-(12-38)-peptide) (His1 12/38) (Histatin 2) (Hst2) (Histatin-2)] |
Synonyms | HIS1 |
Description | FUNCTION: Histatins (Hsts) are cationic and histidine-rich secreted peptides mainly synthesized by saliva glands of humans and higher primates . Hsts are considered to be major precursors of the protective proteinaceous structure on tooth surfaces (enamel pellicle). Hsts can be divided into two major groups according to their biological functions: antimicrobial Hsts (e.g. Hst 5/HTN3) and cell-activating Hsts (e.g. Hst 1/HTN1 and Hst 2/HTN1) . Hst 1/HTN1 and Hst 2/HTN1 act in different cell types (epithelium, fibroblasts and endothelium) in oral and non-oral mucosa . .; FUNCTION: [Histatin-1]: Hst 1 functions primarily as a wound healing factor by activating cell-surface and cell-cell adhesions, cell spreading and migration and it can also stimulate cellular metabolic activity . Hst 1 is internalized in host cells in a stereospecific and energy-dependent process, which is partially mediated by the G protein-coupled receptors (GPCR)-activated endocytosis . Internalized Hst 1 is targeted and released via early endosomes trafficking to the mitochondria, where it significantly enhances mitochondrial energy metabolism . At the mitochondria, Hst 1 increases mitochondria-ER contacts through binding with ER receptor TMEM97, which also stimulates metabolic activity and cell migration and may as well regulate calcium homeostasis of the cell . Also activates the ERK1/2 signaling pathway to promote cell migration, possibly upon interaction with GPRCs at the plasma membrane . Also triggers the RIN2/Rab5/Rac1 signaling cascade which activates endothelial cell adhesion, spreading and migration required for angiogenesis in the oral wound healing process, however the receptor that transduces Hst 1 signal has not yet been identified . Also displays antimicrobial functions against pathogenic yeast Candida albicans, although with less effectiveness than Hst 5 . .; FUNCTION: [His1-(31-57)-peptide]: Hst 2 consists of the fragment sequence 12-28 of Hst 1. Similar to Hst 1, actively and stereospecifically internalized in host cells and targeted to the mitochondria and the ER and promotes cell metabolic activity . Also activates the ERK1/2 signaling pathway to promote cell migration and wound closure . In contrast with Hst 1, not able to promote cell-substrate and cell-cell adhesion . . |
Accessions | ENST00000678229.1 ENST00000511674.5 P15515 ENST00000635327.2 ENST00000246896.8 ENST00000635569.1 |